Company: OTSA
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061733
Chunk: 366

Company: OTSAW Ltd
Filing Date: 2025-07-07
Form: F-1/A
Chunk 366
---
 January20, 2025, following the exercise of options relating to the Swisslog asset acquisition, Otsaw Swisslog Healthcare Robotics Pte. Ltd paid the 3rd and last tranche of SGD800,000 (1,334shares) to Swisslog Healthcare and is then 100% owned by Otsaw Technology Solutions Pte. Ltd. (See Note 15). In January 2025, the Company issued 136,976 new ordinary shares (301,348 prior to the 2025 Reverse Share Split) to its shareholders for a total consideration of USD 550,000. In March 2025, Otsaw Digital Pte Ltd borrowed SGD 500,000 from Capital, Credit & Risk Partners Pte. Ltd. for working capital requirement. The loan is repayable in 3 months and accrues interest at 16% per annum. In March 2025, the Company issued 176,532 new ordinary shares (388,370 prior to the 2025 Reverse Share Split) to its shareholders for a total consideration of USD 530,000. On June20, 2025, the Company effected a reverse share split in which every 2.2 of authorized Class A ordinary shares of par value US$0.0001 each were consolidated into one Class A ordinary share of par value US$0.00022 each (the “2025 Reverse Share Split”). In connection with the 2025 Reverse Share Split, the Company also cancelled 4,999,999 authorized but unissued Class A ordinary shares, resulting in a reduction of our authorized share capital by US$499.9999. Following the 2025 Reverse Share Split and cancellation, our authorized share capital consists of US$49,500.0001 divided into 225,000,001shares, comprising (i) 225,000,000 Class A ordinary shares of par value US$0.00022 each, and (ii) 1 Class B ordinary share of par value US$0.0001. In connection with the 2025 Reverse Share Split, the Company adopted an amended and restated memorandum and articles of association, which took effect upon the completion of the reverse share split. As a result of the 2025 Reverse Share Split, 45,142,208 Class A Ordinary Shares and 1 Class B Ordinary Share are issued and outstanding.

F-83 PART II — INFORMATION NOT REQUIRED IN THE PROSPECTUS Item 6. Indemnification of Directors and